199 related articles for article (PubMed ID: 21543468)
1. Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.
Hu QY; Fink E; Happer M; Elder JH
J Virol; 2011 Jul; 85(14):7108-17. PubMed ID: 21543468
[TBL] [Abstract][Full Text] [Related]
2. Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virus.
Hu QY; Fink E; Grant CK; Elder JH
PLoS One; 2014; 9(12):e115252. PubMed ID: 25521480
[TBL] [Abstract][Full Text] [Related]
3. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication.
de Parseval A; Ngo S; Sun P; Elder JH
J Virol; 2004 Sep; 78(17):9132-43. PubMed ID: 15308709
[TBL] [Abstract][Full Text] [Related]
4. Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.
Sundstrom M; White RL; de Parseval A; Sastry KJ; Morris G; Grant CK; Elder JH
J Virol; 2008 Sep; 82(18):9134-42. PubMed ID: 18596086
[TBL] [Abstract][Full Text] [Related]
5. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.
de Parseval A; Elder JH
J Virol; 2001 May; 75(10):4528-39. PubMed ID: 11312323
[TBL] [Abstract][Full Text] [Related]
6. Replacement of the V3 domain in the surface subunit of the feline immunodeficiency virus envelope glycoprotein with the equivalent region of a T cell-tropic human immunodeficiency virus type 1 results in a chimeric surface protein that efficiently binds to CXCR4.
González SA; Falcón JI; Affranchino JL
AIDS Res Hum Retroviruses; 2014 Mar; 30(3):250-9. PubMed ID: 24148007
[TBL] [Abstract][Full Text] [Related]
7. A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.
Willett BJ; McMonagle EL; Logan N; Samman A; Hosie MJ
Retrovirology; 2008 Aug; 5():77. PubMed ID: 18721458
[TBL] [Abstract][Full Text] [Related]
8. Processing, fusogenicity, virion incorporation and CXCR4-binding activity of a feline immunodeficiency virus envelope glycoprotein lacking the two conserved N-glycosylation sites at the C-terminus of the V3 domain.
González SA; Affranchino JL
Arch Virol; 2016 Jul; 161(7):1761-8. PubMed ID: 27020572
[TBL] [Abstract][Full Text] [Related]
9. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.
Willett BJ; Picard L; Hosie MJ; Turner JD; Adema K; Clapham PR
J Virol; 1997 Sep; 71(9):6407-15. PubMed ID: 9261358
[TBL] [Abstract][Full Text] [Related]
10. Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.
Hu QY; Fink E; Hong Y; Wang C; Grant CK; Elder JH
PLoS One; 2010 May; 5(5):e10689. PubMed ID: 20502526
[TBL] [Abstract][Full Text] [Related]
11. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus.
Willett BJ; Adema K; Heveker N; Brelot A; Picard L; Alizon M; Turner JD; Hoxie JA; Peiper S; Neil JC; Hosie MJ
J Virol; 1998 Aug; 72(8):6475-81. PubMed ID: 9658090
[TBL] [Abstract][Full Text] [Related]
12. Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.
Richardson J; Pancino G; Merat R; Leste-Lasserre T; Moraillon A; Schneider-Mergener J; Alizon M; Sonigo P; Heveker N
J Virol; 1999 May; 73(5):3661-71. PubMed ID: 10196258
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism.
Vahlenkamp TW; Verschoor EJ; Schuurman NN; van Vliet AL; Horzinek MC; Egberink HF; de Ronde A
J Virol; 1997 Sep; 71(9):7132-5. PubMed ID: 9261450
[TBL] [Abstract][Full Text] [Related]
14. Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.
Johnston JB; Power C
J Virol; 2002 Apr; 76(8):3626-36. PubMed ID: 11907202
[TBL] [Abstract][Full Text] [Related]
15. Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.
Hu QY; Fink E; Elder JH
Retrovirology (Auckl); 2012 Jul; 2012(4):1-11. PubMed ID: 23255871
[TBL] [Abstract][Full Text] [Related]
16. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
Celma CC; Paladino MG; González SA; Affranchino JL
Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
[TBL] [Abstract][Full Text] [Related]
17. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
18. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
Lombardi S; Garzelli C; Pistello M; Massi C; Matteucci D; Baldinotti F; Cammarota G; da Prato L; Bandecchi P; Tozzini F
J Virol; 1994 Dec; 68(12):8374-9. PubMed ID: 7966629
[TBL] [Abstract][Full Text] [Related]
19. Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope.
de Parseval A; Grant CK; Sastry KJ; Elder JH
J Virol; 2006 Mar; 80(6):3088-91. PubMed ID: 16501119
[TBL] [Abstract][Full Text] [Related]
20. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells.
Verschoor EJ; Boven LA; Blaak H; van Vliet AL; Horzinek MC; de Ronde A
J Virol; 1995 Aug; 69(8):4752-7. PubMed ID: 7609041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
